HUS Helsinki University Hospital

Neurology

Clinical research activity is centered on reversible cerebral vasoconstriction syndrome, with attention to acute neurological symptoms and recurrent headache patterns.

  • Reversible cerebral vasoconstriction syndrome
  • Recurrent headache attacks
  • Neurological symptom management

The sponsor’s trial activity reflects a focused interest in cerebrovascular disorders affecting patients without major structural findings on CT or MRI.

Cerebrovascular Medicine

Research is directed toward disorders of cerebral blood vessel tone, particularly conditions involving vasoconstriction and vascular instability.

  • Cerebral vasoconstriction
  • Vascular headache syndromes
  • Brain vascular regulation

Interest in this area aligns with clinical care for patients presenting with sudden-onset headache and suspected vascular dysfunction.

Headache Disorders

The sponsor is involved in research on persistent and recurrent headache complaints linked to an underlying vascular syndrome.

  • Recurrent headache
  • Acute headache syndromes
  • Symptom recurrence

This area includes clinical interest in reducing headache burden in patients receiving standard neurological care.

Calcium Channel Blocker Therapy

Trial activity includes evaluation of calcium channel blockers as a therapeutic option in a cerebrovascular headache syndrome.

  • Calcium channel blockers
  • Adjunctive pharmacotherapy
  • Symptom control

The therapeutic focus is on medication-based management for reducing recurrent headache episodes in reversible cerebral vasoconstriction syndrome.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study on Amlodipine for Treating Reversible Cerebral Vasoconstriction Syndrome in Patients Without Brain Lesions or Hemorrhage

    Not yet recruiting

    1 1 1 1
    Investigated drugs:
    Finland